This inventor holds 3 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Hendrix College, The Ohio State University. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3 
3 out of 1,584 
Years Active: 2022-2026
Title: Innovations and Contributions of Chad E Bennett
Introduction
Chad E Bennett is a notable inventor based in Powell, Ohio, who has made significant contributions to the field of pharmacology. With a total of two patents to his name, Bennett's work focuses on innovative methods and compositions that have the potential to impact the treatment of various diseases.
Latest Patents
Bennett's latest patents include groundbreaking research on methods and compositions for the inhibition of dihydroorotate dehydrogenase (DHODH). The disclosed compounds, specifically 3,4,6,8-substituted-2-([1,1'-biphenyl]-4-yl)quinoline analogs, serve as inhibitors of DHODH with improved pharmacokinetic properties. These compounds are particularly useful in treating a range of disorders, including hematological cancers such as acute myeloid leukemia (AML), graft-versus-host diseases, autoimmune disorders, and conditions associated with T-cell proliferation. Notably, the compounds exhibit flip-flop kinetics when administered orally, indicating that the rate of absorption is more significant than the rate of elimination. This results in a sustained pharmacokinetic profile rather than an immediate release profile.
Career Highlights
Throughout his career, Chad E Bennett has been associated with reputable organizations such as the Ohio State Innovation Foundation and Hendrix College. His work in these institutions has allowed him to further his research and contribute
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile